Rainbow Childrens MedicareQ3 FY24

Rainbow Childrens Medicare Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,270.4P/E: 44.0Market Cap: ₹12.9K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Mature hospitals showed ~12% top-line growth in nine months but data isn't fully like-to-like due to hospital lifecycle transitions.
  • Expected steady growth in mature hospitals with SSG (Same Store Growth) around 11-12%.
  • Expansion plans include adding ~200–280 beds annually, with new hospitals (e.g., in Hyderabad, Rajahmundry, Coimbatore, Bangalore) planned or underway.
  • New hospitals like those in Hyderabad expected to break even quickly, while others (Sarjapur, Anna Nagar) may take 12-15 months to breakeven.
  • Occupancy targeted at ~55% consolidated, with mature hospitals aiming >60%, despite addition of new beds diluting occupancy short term.
  • Increase in ARPOB driven by better case mix and specialty services, supporting revenue growth even with seasonal occupancy dips.
  • Market growth fueled by rising awareness, insurance penetration, and expansion into mother and child care segments, including higher demand in Tier 2 cities planned for long term.
  • Pricing increases linked to inflation (~6-7% annually) expected to provide ongoing revenue support.

See what Rainbow Childrens Medicare management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
- The company remains confident in completing all planned capital expenditures through internal accruals without any debt financing. - As of December 31, 2023, Rainbow Children's Medicare Limited had a net cash position of INR 495 crores to support ongoing capex plans. - No mention was made of any current or future fundraising through debt or equity during the call. - The management highlighted they will fund expansions primarily via internal accruals, avoiding additional debt. - They have invested approximately INR 60 crores in capex during the recent quarter from existing resources. In summary, Rainbow Children’s Medicare Limited does not currently plan to raise funds through new debt or equity and aims to fund growth from internal cash flows.

See what Rainbow Childrens Medicare management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company plans to add 280 beds in the current financial year as budgeted.
  • Project work is underway for a spoke hospital at Hennur, Bangalore (~60 beds) and a regional greenfield hospital of 100 beds at Rajahmundry, Andhra Pradesh, expected to commence operations towards the end of the next financial year.
  • A new greenfield hospital of 125 beds in Coimbatore is planned, with project work expected to start soon (likely February).
  • In the National Capital Region (NCR), two land parcels in Gurgaon have been purchased, with efforts ongoing to secure possession and progress architectural planning for new hospitals.
  • Capex per bed, factoring in inflation, is currently estimated at INR 65-75 lakhs per bed for hub and spoke models.
  • The company remains confident in completing all planned capital expenditures through internal accruals without any debt financing.

Track Rainbow Childrens Medicare — get its next earnings analysis in your feed

How does Rainbow Childrens Medicare rank vs peers in Healthcare Services?

Pro feature
ThisRainbow Childrens Medicare
Rev 3Mar 3

How does Rainbow Childrens Medicare rank in Healthcare Services?

Compare Rainbow Childrens Medicare against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →